Business Wire

XPRIZE

31.5.2019 21:28:12 CEST | Business Wire | Press release

Share
Winners Announced in $7M Shell Ocean Discovery XPRIZE for Advancements in Autonomous Ocean Exploration

Today, XPRIZE , the global leader in designing and operating incentive competitions to solve humanity’s grand challenges, has announced winners in the $7M Shell Ocean Discovery XPRIZE , a global competition to advance ocean technologies for rapid, unmanned and high-resolution ocean exploration and discovery.

The results were revealed at an awards ceremony hosted at the world-renowned Oceanographic Museum of Monaco, part of the Oceanographic Institute, Prince Albert I of Monaco Foundation. The grand prize winner, receiving a total of $4M, was GEBCO-NF Alumni , an international team based in the United States, while KUROSHIO , from Japan, claimed $1M as the runner-up:

  • GEBCO-NF (International) – Led by Rochelle Wigley, Ph.D. and Yulia Zarayskaya, Ph.D., the 14-nation team integrated existing technologies and ocean-mapping experience with a robust and low-cost unmanned surface vessel, the SeaKIT, along with a novel cloud-based data processing system that allows for rapid seabed visualization, to contribute towards comprehensive mapping of the ocean floor by 2030.
  • KUROSHIO   (Yokosuka, Japan) – Led by Takeshi Nakatani, Ph.D., the team integrated technologies from their partners to create a surface vessel and software platform that can operate with different autonomous underwater vessels, which increases the versatility of their technology.

The $1M National Oceanic and Atmospheric Administration (NOAA) Bonus Prize for teams to develop technology that could detect a chemical or biological signal underwater and autonomously track it to its source was split between junior high school team Ocean Quest from San Jose, California, claiming $800K as the winner, and Tampa Deep Sea Xplorers , from Florida, taking $200K as runner-up.

“Currently, more than 80 percent of the world’s ocean is unmapped, and I'm proud to have worked alongside the people who will change this as a part of this XPRIZE,” said Executive Director of the Ocean Discovery XPRIZE, Jyotika Virmani, Ph.D. “Our vision is that these new technologies will enable the discovery of new ocean species, underwater resources, geological features, and safer methods of exploring the deep sea, while illuminating the mysteries of the deep and discovering what has remained unknown since the dawn of time.”

Additionally, the judges unanimously recommended a $200K “Moonshot Award” for Team Tao from the United Kingdom for its unique approach to seafloor mapping, even though they did not meet the criteria of the competition.

“The Ocean Discovery XPRIZE teams' accomplishments are a true reflection of XPRIZE’s core belief that incentivizing the crowd will drive innovation and investment, leading to a massive shift in the state of the market,” said Anousheh Ansari, CEO of XPRIZE. “It is an honor to celebrate the winning teams GEBCO-NF Alumni, KUROSHIO, Ocean Quest, Tampa Deep Sea Xplorers, as well as Team Tao for their unprecedented, radical approach. We look forward to watching these pioneers shape the future of ocean exploration and discovery.”

To determine winners, the panel of independent judges reviewed data from field testing conducted in Kalamata, Greece and Ponce, Puerto Rico. In Kalamata, teams had up to 24 hours to map at least 250 km2 of the ocean seafloor at 5m horizontal resolution or higher. The gold-standard high-resolution baseline maps, against which the team maps were judged, were provided by Ocean Infinity and Fugro, while Esri, the global leader in geographic information system (GIS) software and geodatabase management, donated its award-winning ArcGIS Online platform for the teams and judges to use.

“At Shell, we are firm believers in the power of ideas and the value of collaboration to solve big problems,” said Martin Stauble, Shell’s Vice President Exploration North America and Brazil. “We are proud to be part of the Shell Ocean Discovery XPRIZE. This prize energized teams from across the globe and stimulated innovation, technology and learning, all in support of providing data for a better understanding of our oceans. We hope that the XPRIZE results will be a catalyst to create a step-change in the speed and quality of data that companies, research institutes and society can use.”

As part of the total $7M prize purse, four teams opted to compete for the $1M NOAA Bonus Prize. In a field test in Ponce, Puerto Rico, teams needed to demonstrate that their technology can “sniff out” a specified object in the ocean by first detecting and then tracing a biological or chemical signal to its source. The judges determined that no single team was able to trace the signal to its source in the timeframe allowed, so the prize was divided among the two teams that came the closest.

Last year, nine finalist teams were awarded an equal share of the first $1M of the $7M prize purse, in recognition of their progress-to-date and to support the teams’ continued technological development.

“NOAA is proud to support this important competition that is accelerating the development of new unmanned tools capable of tracking chemical and biological signals in our ocean,” said Neil Jacobs, Ph.D., acting NOAA administrator. “The cutting-edge technologies that have emerged as a result of the NOAA Bonus Prize will help fuel a growing Blue Economy and inspire future innovation.”

As part of its post-prize impact work, XPRIZE announced a partnership with Seabed 2030, a collaborative project between The Nippon Foundation and The General Bathymetric Chart of the Oceans (GEBCO) to inspire the complete mapping of the world’s ocean by 2030 and to compile all bathymetric data into the freely-available GEBCO Ocean Map.

Additionally, and in anticipation of World Oceans Day on June 8th, XPRIZE will launch a science fiction ocean anthology featuring 19 original short stories and artwork set in a future when technology has helped unlock the secrets of the world’s oceans.

For more information, visit oceandiscovery.xprize.org .

About XPRIZE

XPRIZE designs and operates multi-million-dollar, global competitions to incentivize the development of technological breakthroughs that accelerate humanity toward a better future. Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, the $10 Million ANA Avatar XPRIZE and the $5 Million IBM Watson AI XPRIZE. For more information, visit xprize.org .

About Royal Dutch Shell

Shell has been a technology pioneer for more than 100 years, and has come up with many industry-transforming “firsts” to deliver energy its customers and partners need. Since 2007, Shell has spent more than $1 billion annually on research and development. In 2014, our research and development expenditures were $1.2 billion. Shell’s technical and engineering staff amount to more than 43,000.

Shell companies have operations in more than 70 countries and territories with businesses including oil and gas exploration and production; production and marketing of liquefied natural gas and gas to liquids; manufacturing, marketing and shipping of oil products and chemicals and renewable energy projects. Royal Dutch Shell plc is incorporated in England and Wales, has its headquarters in The Hague and is listed on the London, Amsterdam, and New York stock exchanges. For further information, visit www.shell.com .

About National Oceanic and Atmospheric Administration (NOAA)

The National Oceanic and Atmospheric Administration (NOAA) is a science-based federal agency within the Department of Commerce with regulatory, operational and information service responsibilities with a presence in every state and U.S. territories. NOAA's mission is to understand and predict changes in the Earth's environment, from the depths of the ocean to the surface of the sun, and to conserve and manage coastal and marine resources. For more information, visit www.noaa.gov .

Contact:

Eric Desatnik & Katherine Schelbert 310.741.4880 / eric@xprize.org katherine.schelbert@xprize.org

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye